ALB and type 2 diabetes mellitus: A prospective 8-year study of patients with T2DM conducted in the UK showed that those with abnormal albumin excretion had significantly higher risks of all-cause mortality (odds ratio [OR], 1.47; p = 0.02) and vascular death (OR, 1.70; p = 0.009) than did those with normal albumin excretion, with the differences observed at all levels of abnormal albumin excretion, from just outside the normal range (10.6–29.9 μg/min) to microalbuminuria (≥30 μg/min) [82].